Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.


Guest blog: Dr Whitney Jones weighs in on Colon Cancer Awareness Month

The purpose of this post is to thank our community of physicians, nurses, scientists and industry for their leadership in making a real difference in the public health of the nation through colorectal cancer (CRC) screening.

Yet, if we are to hit the lofty goals set by the National Colorectal Cancer Roundtable for 2018 of screening 80 percent of the population at risk, we must work even harder and smarter as we have challenging and important work ahead of us.

Several issues stand out.

First, those of us who fight CRC everyday must find a way to engage and ramp up enthusiasm, effectiveness and efficiency of CRC screening at the primary care provider and medical home platforms.

Second, endoscopists need to embrace and support evolving, non-invasive methods to rapidly maximise the number of persons at risk receiving appropriate screening in the shortest time frame possible.

Third, the national CRC community should dedicate itself to improving screening rates in the worst screening states. To be clear, this generally refers to the broad south and the Appalachian states. Compassion and our goals dictate that their success is our success. We must invest through specific policies that deliver expertise, models, and insights as well as equalising taxpayer supported resources from existing agencies (Screen for Life, CDC) to states with the lowest screening rates and therefore in the greatest need.

Finally, we need a new communication strategy to better serve our current screening and diagnostic guidelines. Ten percent of CRC cases now affect people under age 50 and the percentage of rectal cancers under age 50 now approaches 20 percent – a doubling in the last decade alone. By no later that age 40, providers and patients should be made aware of CRC facts including: timely identification and action on pertinent family histories, information about symptoms to reduce delays in diagnosis for those under 50 and importantly to precondition those at normal risk for screening at age 50.

Let’s continue the work together as we make deaths from CRC a thing of the past.

Dr Whitney Jones is not a paid consultant of Cook Medical.

Thank You for Your Interest in Cook Medical's Products

The product information on this website is intended only for physicians and healthcare professionals licensed in the European Union (except France), the United Kingdom, Switzerland, Norway, Iceland, Turkey, and Liechtenstein. If you are located in another global region, please click on the regional flag at the very top of the webpage and choose your region from the drop-down options.

If your region is not listed, visit our How to Order section for more information.

Information provided on this site is not intended to be professional medical advice. Product Instructions for Use (IFU) should be consulted before use of any product.